Dr. Haroon Rehman, MD

Dr. Rehman practices at Mercy Medical Group, A Service Of Dignity Health Medical Foundation in Carmichael, California.

Dr. Rehman's NPI, 1952784852, was assigned on July 9, 2015. Dr. Rehman graduated from Ross University School of Medicine in 2014. Dr. Rehman holds California license A168291.

Dr. Rehman's primary practice is Mercy Medical Group, A Service of Dignity Health Medical Foundation, at 6511 Coyle Ave, Carmichael, CA 95608-0306. The practice phone is (916) 556-3300.

Dr. Rehman's primary practice is Mercy Medical Group, A Service Of Dignity Health Medical Foundation in Carmichael, California. Dr. Rehman is also affiliated with Dignity Health - Mercy San Juan Medical Center. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Rehman to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rehman practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Rehman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Rehman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rehman's licenses on file in 2 states: California and Ohio.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Rehman treats.

CMS data shows 1,207 Medicare services from Dr. Rehman across 5 procedure codes in 2024, all of them office visits, for 463 Medicare patients. Medicare paid $93,434 for them.

CMS counts 463 Medicare patients who saw Dr. Rehman in 2024. The largest group is 65 to 74, with 191 patients. 73% of them have high blood pressure, and 67% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rehman's median patient age at 65, with 66% women.

In 2024, Dr. Rehman wrote 1,612 Medicare Part D claims for 246 patients. 87% of them were for generic drugs. CMS names the drug for 1,343 of them, across 39 drugs with 11 or more claims each, at $1,723,619 in total drug cost. In 2023, CMS named 1,343 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rehman for performance year 2024, reported through an alternative payment model (APM). Dr. Rehman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rehman as offering telehealth.

Dmand AI links 29 papers to Dr. Rehman, published from 2011 to 2021. 2015 was the busiest year, with 6. The most frequent topics are Laparoscopy, Appendectomy and Randomized Controlled Trials as Topic. Dr. Rehman has published most often in Int J Surg. Dr. Rehman's most frequent co-authors are Irfan B. Ahmed, MD, Haroon Ur Rehman, MD and Omar Aly.

CMS Open Payments shows 5 general payments to Dr. Rehman from 1 drug or device company from 2021 to 2023. Education make up the largest share, 100% of the total. Pfizer Inc. paid the most, $114.

Dr. Rehman graduated from Ross University School of Medicine in 2014.

Dr. Rehman is in network with 13 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.